REQUEST A DEMO
Total
USD $0.00
Search more companies

Corporacion Para Investigaciones Biologicas Cib (Colombia)

Main Activities: Scientific Research and Development Services
Full name: Corporacion Para Investigaciones Biologicas Cib Profile Updated: August 01, 2019
Buy our report for this company USD 29.95 Most recent financial data: 2025 Available in: English & Spanish Download a sample report

Corporacion Para Investigaciones Biologicas Cib is an enterprise located in Colombia, with the main office in Medellin. The company operates in the Scientific Research and Development Services sector. It was established on May 06, 2026. From the latest financial highlights, Corporacion Para Investigaciones Biologicas Cib reported a net sales revenue drop of 37.69% in 2025. Its’ total assets recorded a negative growth of 4.51%. The net profit margin of Corporacion Para Investigaciones Biologicas Cib decreased by 1.12% in 2025.

Headquarters
Kr 72 A #78 B 141
Medellin; Antioquia;

Contact Details: Purchase the Corporacion Para Investigaciones Biologicas Cib report to view the information.

Basic Information
Registered Capital:
Purchase the Corporacion Para Investigaciones Biologicas Cib report to view the information.
Financial Auditors:
Purchase the Corporacion Para Investigaciones Biologicas Cib report to view the information.
Incorporation Date:
May 06, 2026
Key Executives
Purchase this report to view the information.
Legal Representative
Company Performance
Financial values in the chart are available after Corporacion Para Investigaciones Biologicas Cib report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency COP. Absolute financial data is included in the purchased report.
Net sales revenue
-37.69%
Total Operating Revenue
-37.69%
Operating Profit
-769.29%
EBITDA
N/A
Net Profit/Loss for the Period
-88.13%
Total Assets
-4.51%
Total Equity
-5.48%
Operating Profit Margin
-58.32%
Net Profit Margin
-1.12%
Return on Equity (ROE)
-0.83%
Debt / Equity
-0.06%
Quick Ratio
-0.01%
Cash Ratio
-0.03%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?